How many migraine patients need prolonged (>1 year) preventive treatment? Experience with topiramate

Author： Pascual J.   Berdei Y.   Gómez-Sánchez J.  

Publisher： Springer Publishing Company

ISSN： 1129-2369

Source： The Journal of Headache and Pain, Vol.8, Iss.2, 2007-04, pp. : 90-93

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Topiramate in the Treatment of Chronic Migraine

By Azimova Yu.   Tabeeva G.  

Neuroscience and Behavioral Physiology, Vol. 44, Iss. 3, 2014-03 ,pp. : 310-314

Springer Publishing Company

Access to resources Recommend Favorite

Gingkolide B as migraine preventive treatment in young age: results at 1-year follow-up

By Usai Susanna   Grazzi Licia   Bussone Gennaro  

Neurological Sciences, Vol. 32, Iss. 1, 2011-05 ,pp. : 197-199

Springer Publishing Company

Access to resources Recommend Favorite

How intensive/prolonged should an intensive/prolonged treatment be?

By Basso Anna  

Aphasiology, Vol. 19, Iss. 10-11, 2005-11 ,pp. : 975-984

Routledge Ltd

Access to resources Recommend Favorite

Topiramate in migraine prophylaxis

By Diener Hans-Christoph   Tfelt-Hansen P.   Dahlöf C.   Láinez M.   Sandrini G.   Wang Sh.-J.   Neto W.   Vijapurkar U.   Doyle A.   Jacobs D.  

Journal of Neurology, Vol. 251, Iss. 8, 2004-08 ,pp. : 943-950

Springer Publishing Company

Access to resources Recommend Favorite

Topiramate in migraine prophylaxis

By Láinez Miguel JA  

Future Neurology, Vol. 1, Iss. 4, 2006-07 ,pp. : 357-364

Future Medicine

Access to resources Recommend Favorite